Concerning the photophysics of fluorophores towards tailored bioimaging compounds: a case study involving S100A9 inflammation markers
-
Published:2023-06-11
Issue:9
Volume:22
Page:2093-2104
-
ISSN:1474-905X
-
Container-title:Photochemical & Photobiological Sciences
-
language:en
-
Short-container-title:Photochem Photobiol Sci
Author:
Steiner Simon T.ORCID, Maisuls IvánORCID, Junker Anna, Fritz GünterORCID, Faust Andreas, Strassert Cristian A.ORCID
Abstract
AbstractA full understanding concerning the photophysical properties of a fluorescent label is crucial for a reliable and predictable performance in biolabelling applications. This holds true not only for the choice of a fluorophore in general, but also for the correct interpretation of data, considering the complexity of biological environments. In the frame of a case study involving inflammation imaging, we report the photophysical characterization of four fluorescent S100A9-targeting compounds in terms of UV–vis absorption and photoluminescence spectroscopy, fluorescence quantum yields (ΦF) and excited state lifetimes (τ) as well as the evaluation of the radiative and non-radiative rate constants (kr and knr, respectively). The probes were synthesized based on a 2-amino benzimidazole-based lead structure in combination with commercially available dyes, covering a broad color range from green (6-FAM) over orange (BODIPY-TMR) to red (BODIPY-TR) and near-infrared (Cy5.5) emission. The effect of conjugation with the targeting structure was addressed by comparison of the probes with their corresponding dye-azide precursors. Additionally, the 6-FAM and Cy5.5 probes were measured in the presence of murine S100A9 to determine whether protein binding influences their photophysical properties. An interesting rise in ΦF upon binding of 6-FAM-SST177 to murine S100A9 enabled the determination of its dissociation equilibrium constant, reaching up to KD = 324 nM. This result gives an outlook for potential applications of our compounds in S100A9 inflammation imaging and fluorescence assay developments. With respect to the other dyes, this study demonstrates how diverse microenvironmental factors can severely impair their performance while rendering them poor performers in biological media, showing that a preliminary photophysical screening is key to assess the suitability of a particular luminophore.
Funder
Innovative Medicines Initiative CiM-IMPRS Deutsche Forschungsgemeinschaft Westfälische Wilhelms-Universität Münster
Publisher
Springer Science and Business Media LLC
Subject
Physical and Theoretical Chemistry
Reference50 articles.
1. Foell, D., Wittkowski, H., Vogl, T., & Roth, J. (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology, 81, 28–37. https://doi.org/10.1189/jlb.0306170 2. Foell, D., & Roth, J. (2004). Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis and Rheumatism, 50, 3762–3771. https://doi.org/10.1002/art.20631 3. Chang, K.-A., Kim, H. J., & Suh, Y.-H. (2012). The role of S100a9 in the Pathogenesis of Alzheimer’s Disease: the therapeutic effects of S100a9 knockdown or knockout. Neuro-Degenerative Diseases, 10, 27–29. https://doi.org/10.1159/000333781 4. Arai, K., Takano, S., Teratani, T., Ito, Y., Yamada, T., & Nozawa, R. (2008). S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Current Cancer Drug Targets, 8, 243–252. https://doi.org/10.2174/156800908784533445 5. Björk, P., Björk, A., Vogl, T., Stenström, M., Liberg, D., Olsson, A., Roth, J., Ivars, F., & Leanderson, T. (2009). Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biology, 7, 0800–0812. https://doi.org/10.1371/journal.pbio.1000097
|
|